RTW Investments, LP 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 10:07 am Purchase | 2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | RTW Investments, LP | 5,106,341 9.900% | 2,243,143 (+78.34%) | Filing |
| 2022-02-14 08:55 am Purchase | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | RTW Investments, LP | 2,863,198 5.600% | 2,863,198 (New Position) | Filing |